Targeting gene regulators for cancer therapy: Antisense inhibitors provide new sites for intervention

Modern Drug Discovery

Volumn 3, Issue 3, 2000, Pages 51-58

  Besterman, Jeffrey M ^a   Macleod, A Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007655375     PISSN: 10998209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Razin, A.; Szyf, M. DNA methylation patterns. Formation and function. Biochem. Biophys. Acta 1984, 782, 331-342.
2. Li, E.; Bester, T. H.; Jaenisch, R. Targeted mutation of the DNA methyltranferase gene results in embryonic lethality. Cell 1992, 69, 915-926.
3. Okano, M., et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99, 247-257.
4. MacLeod, A. R.; Rouleau, J.; Szyf, M. Regulation of DNA methylation by the Ras signaling pathway. J. Biol. Chem. 1995, 270, 11327-11337.
5. Gonzalez-Zulueta, M., et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995, 55, 4531-4535.
6. Merlo, A., et al. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1995, 1, 686-692.
7. Costello, J. F., et al. Silencing of p166/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res. 1996, 56, 2405-2410.
8. Lo, K. W., et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res. 1996, 56, 2721-2725.
9. WAF1/CIP1 by distinct mechanisms. J. Biol. Chem. 1999, 274, 24250-24256.
10. Yoshida, M., et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 1990, 265, 17174-17179.